DUBLIN, July 16, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ff25lf/contrast) has announced the addition of the "Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020" report to their offering.
The global contrast media market for the forecast period of 2015 to 2020. This market is expected to reach a value of $5.17 Billion by 2020, from $4.21 Billion in 2015, at a CAGR of 4.2% during the period under consideration. The market is expected to be dominated by North America in 2015, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific market is expected to grow at the highest CAGR during the given forecast period.
The global contrast agents market has been segmented on the basis of product, route of administration, indication, procedure, application, and region. In terms of product, the market is categorized into barium, iodinated, gadolinium, and microbubble contrast media. In 2015, the iodinated contrast media segment is estimated to account for the largest share of the contrast agents market, among the products. However, the microbubble contrast media market is expected to grow at the highest CAGR during the forecast period of 2015 to 2020.
On the basis of route of administration, the global market has been segmented into oral, injectable, rectal, and urethral routes. In 2015, the injectable segment is expected to account for the largest share of the market, among the different routes of administration.
The contrast media market, by indication, has been segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. In 2015, the cardiovascular disorders segment is estimated to dominate the market, among indications.
Based on application, the market has been segmented into radiology, interventional radiology, and interventional cardiology. In 2015, the radiology segment is estimated to account for the largest share of the market, among the applications.
The key factors that are expected to drive the growth of this market include the increase in demand for diagnostics and image-guided procedures; increase in approvals for various contrast agents; and increase in aging population and the incidence of chronic diseases. In addition, the improving healthcare infrastructure in emerging markets and the increase in the number of public and private diagnostic centers are further propelling the growth of the global contrast media/contrast agents market. Moreover, the strong product pipelines of the major market players, along with the increasing research studies regarding applications of various contrast agents, are expected to provide opportunities for further market growth in the near future.
Some of the major players in the global market include Bayer Healthcare (Germany), GE Healthcare (U.K.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Mallinckrodt PLC (Ireland), and Lantheus Medical Imaging (U.S.), among others.
Full List of Companies Mentioned
- Bayer Healthcare - Bracco Imaging S.P.A. (A Subsidiary Of Bracco S.P.A.) - CMC Contrast Ab - Daiichi Sankyo - GE Healthcare - Guerbet Group - Lantheus Medical Imaging - Mallinckrodt Plc - Nanopet Pharma Gmbh - Subhra Pharma Private Limited - Targeson, Inc. Pharma Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/ff25lf/contrast
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets